<!DOCTYPE html>
<html lang="en">

<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Model Comparison: Opus KG-mcp vs. Opus Plain</title>
  <style>
    *,
    *::before,
    *::after {
      box-sizing: border-box;
      margin: 0;
      padding: 0;
    }

    body {
      font-family: 'Georgia', serif;
      font-size: 14px;
      color: #1a1a1a;
      background: #fff;
      padding: 48px 40px;
      max-width: 1100px;
      margin: 0 auto;
      line-height: 1.65;
    }

    header {
      border-bottom: 2px solid #1a1a1a;
      padding-bottom: 16px;
      margin-bottom: 10px;
    }

    header h1 {
      font-size: 20px;
      font-weight: bold;
      letter-spacing: 0.02em;
    }

    header p {
      font-size: 12px;
      color: #555;
      margin-top: 4px;
    }

    .legend {
      display: flex;
      gap: 24px;
      margin: 18px 0 32px;
      font-size: 12px;
      color: #444;
    }

    .legend span {
      display: flex;
      align-items: center;
      gap: 6px;
    }

    .legend-dot {
      width: 10px;
      height: 10px;
      border-radius: 50%;
      display: inline-block;
    }

    .dot-kg {
      background: #2a2a2a;
    }

    .dot-plain {
      background: #888;
    }

    .question-block {
      margin-bottom: 48px;
    }

    .question-label {
      font-size: 11px;
      text-transform: uppercase;
      letter-spacing: 0.1em;
      color: #888;
      margin-bottom: 4px;
    }

    .question-text {
      font-size: 15px;
      font-weight: bold;
      margin-bottom: 18px;
      color: #111;
      border-left: 3px solid #1a1a1a;
      padding-left: 10px;
    }

    .comparison-grid {
      display: grid;
      grid-template-columns: 1fr 1fr;
      border: 1px solid #ddd;
    }

    .col-header {
      padding: 10px 14px;
      font-size: 11px;
      font-weight: bold;
      text-transform: uppercase;
      letter-spacing: 0.08em;
      border-bottom: 1px solid #ddd;
    }

    .col-header.kg {
      background: #1a1a1a;
      color: #fff;
      border-right: 1px solid #ddd;
    }

    .col-header.plain {
      background: #f0f0f0;
      color: #333;
    }

    .cell {
      padding: 14px 16px;
      vertical-align: top;
    }

    .cell.kg {
      border-right: 1px solid #ddd;
      background: #fafafa;
    }

    .cell.plain {
      background: #fff;
    }

    .cell-section-label {
      font-size: 10px;
      text-transform: uppercase;
      letter-spacing: 0.1em;
      color: #999;
      margin-bottom: 5px;
      font-family: 'Courier New', monospace;
    }

    .cell-content {
      font-size: 13.5px;
      color: #222;
    }

    .reasoning-body {
      overflow: hidden;
      transition: max-height 0.3s ease;
    }

    .reasoning-body.collapsed {
      display: -webkit-box;
      -webkit-line-clamp: 2;
      -webkit-box-orient: vertical;
      overflow: hidden;
    }

    .cell-content.collapsed {
      display: -webkit-box;
      -webkit-line-clamp: 2;
      -webkit-box-orient: vertical;
      overflow: hidden;
    }

    .show-toggle {
      display: inline-block;
      margin-top: 5px;
      font-size: 11px;
      color: #aaa;
      cursor: pointer;
      user-select: none;
      font-family: 'Courier New', monospace;
      letter-spacing: 0.04em;
    }

    .show-toggle:hover {
      color: #555;
    }

    .divider-row {
      grid-column: 1 / -1;
      height: 1px;
      background: #e0e0e0;
    }

    .notes-row {
      grid-column: 1 / -1;
      background: #fffdf4;
      border-top: 1px solid #e8e0c0;
      padding: 12px 16px;
    }

    .notes-label {
      font-size: 10px;
      text-transform: uppercase;
      letter-spacing: 0.1em;
      color: #b0902a;
      margin-bottom: 4px;
      font-family: 'Courier New', monospace;
    }

    .notes-content {
      font-size: 13px;
      color: #555;
      font-style: italic;
    }

    h1,
    h2,
    h3 {
      color: #333;
      margin-top: 0.8em;
      margin-bottom: 0.5em;
    }

    h1 {
      font-size: 2em;
    }

    h2 {
      font-size: 1.5em;
    }

    h3 {
      font-size: 1.2em;
    }

    code {
      background: #f4f4f4;
      padding: 2px 4px;
      border-radius: 3px;
      font-family: 'Courier New', monospace;
    }

    pre {
      background: #f4f4f4;
      padding: 15px;
      border-radius: 5px;
      overflow-x: auto;
      font-family: 'Courier New', monospace;
      line-height: 1.4;
    }

    blockquote {
      border-left: 4px solid #ddd;
      margin: 1em 0;
      padding-left: 20px;
      color: #ffffff;
      font-style: italic;
      background-color: #444;
    }

    table {
      border-collapse: collapse;
      width: 100%;
      margin: 1em 0;
    }

    th,
    td {
      border: 1px solid #ddd;
      padding: 8px 12px;
      text-align: left;
    }

    th {
      background-color: #f5f5f5;
      font-weight: bold;
    }

    ul,
    ol {
      margin: 1em 0;
      padding-left: 2em;
    }

    li {
      margin: 0.5em 0;
    }
  </style>
</head>

<body>

  <header>
    <h1>Model Response Comparison: Opus KG-mcp vs. Opus Plain</h1>
    <p>Domain: Neurodevelopmental Biology &nbsp;·&nbsp; Format: Reasoning + Direct Response &nbsp;·&nbsp; Evaluated: 3
      questions</p>
  </header>

  <div class="legend">
    <span><span class="legend-dot dot-kg"></span> Opus KG-mcp — knowledge-graph augmented</span>
    <span><span class="legend-dot dot-plain"></span> Opus Plain — baseline model</span>
  </div>

  <!-- QUESTION 1 -->
  <div class="question-block">
    <div class="question-label">Question 1</div>
    <div class="question-text">Considering that the medial eminence is exposed to vascularisation, which tanycyte
      subtypes would you expect to show the strongest increase in immune programs in aging?</div>
    <div class="comparison-grid">
      <div class="col-header kg">Opus KG-mcp</div>
      <div class="col-header plain">Opus Plain</div>

      <div class="cell kg">
        <div class="cell-section-label">Reasoning</div>
        <div class="cell-content">
          <div class="reasoning-body collapsed">
            <h3>Tanycyte subtype identity from the graph</h3>
            <p>Based on spatial mapping and transcription factor profiles, the 8 tanycyte clusters map to classical
              subtypes as follows:</p>
            <table>
              <thead>
                <tr>
                  <th>Cluster</th>
                  <th>Supertype</th>
                  <th>Primary region</th>
                  <th>Classical identity</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td>5243</td>
                  <td>NN_1</td>
                  <td>Choroid plexus / SFO</td>
                  <td>CVO-associated</td>
                </tr>
                <tr>
                  <td>5244</td>
                  <td>NN_1</td>
                  <td>AVPV / OVLT</td>
                  <td>CVO-associated</td>
                </tr>
                <tr>
                  <td>5245</td>
                  <td>NN_2</td>
                  <td>PVi (88%)</td>
                  <td><strong>β1-tanycyte</strong></td>
                </tr>
                <tr>
                  <td>5246</td>
                  <td>NN_2</td>
                  <td>PVi + ARH</td>
                  <td><strong>β2-tanycyte</strong></td>
                </tr>
                <tr>
                  <td>5247</td>
                  <td>NN_2</td>
                  <td>ARH (60%) + PVp</td>
                  <td><strong>╬▓1-tanycyte</strong></td>
                </tr>
                <tr>
                  <td>5248</td>
                  <td>NN_2</td>
                  <td>PVp + V3</td>
                  <td>β2-posterior</td>
                </tr>
                <tr>
                  <td>5249</td>
                  <td>NN_2</td>
                  <td>ARH (76%) + V3</td>
                  <td><strong>╬▓1-tanycyte</strong></td>
                </tr>
                <tr>
                  <td><strong>5250</strong></td>
                  <td><strong>NN_3</strong></td>
                  <td><strong>ME (46%)</strong> + ARH</td>
                  <td><strong>╬▓2-tanycyte</strong></td>
                </tr>
              </tbody>
            </table>
            <h3>Ranked predictions</h3>
            <p><strong>1. ╬▓2-tanycytes (cluster 5250 / Tanycyte NN_3) - strongest effect</strong></p>
            <ul>
              <li><strong>Only tanycyte cluster with direct ME mapping</strong> (fraction = 0.46) - no other tanycyte
                cluster shows any ME signal.</li>
              <li>╬▓2-tanycytes line the ventral floor of the 3rd ventricle and extend processes into the ME external
                zone, where they directly contact <strong>fenestrated capillaries</strong> of the
                hypothalamic-hypophyseal portal system. These capillaries lack a blood-brain barrier.</li>
              <li>This makes ╬▓2-tanycytes the primary cellular interface between peripheral blood and the CNS at the
                ME. During aging, rising levels of circulating pro-inflammatory cytokines (IL-6, TNF-β, IL-1╬▓ -
                &quot;inflammaging&quot;) would directly stimulate these cells.</li>
              <li>The marker <strong>Ecrg4</strong> (augurin) is notable: it encodes a secreted peptide that is cleaved
                under inflammatory conditions and has been shown to activate innate immune pathways. Its expression in
                ╬▓2-tanycytes supports a role as an immune sentinel.</li>
              <li>TF <strong>Fosb</strong> (an immediate-early gene/AP-1 component) suggests these cells are
                particularly responsive to extracellular stimuli, including inflammatory signaling cascades.</li>
            </ul>
            <p><strong>2. ╬▓1-tanycytes (clusters 5247, 5249 / Tanycyte NN_2 subset) - moderate effect</strong></p>
            <ul>
              <li>Map predominantly to the <strong>arcuate nucleus</strong> (ARH), which sits immediately adjacent to
                the ME and receives vascular leakage from ME fenestrated capillaries.</li>
              <li>╬▓1 processes extend laterally along the ME border, giving them partial exposure to blood-borne
                signals.</li>
              <li>They would receive paracrine inflammatory signals from ╬▓2-tanycytes and experience indirect BBB
                compromise.</li>
              <li>TFs <strong>Tbx3</strong> (5247) and <strong>Six6</strong> (5249) suggest distinct functional
                identities but shared vascular adjacency.</li>
            </ul>
            <p><strong>3. β2-tanycytes (cluster 5246) - lower but non-negligible</strong></p>
            <ul>
              <li>Map to PVi + ARH, more dorsal than ╬▓-tanycytes.</li>
              <li>Notably, <strong>Dock8</strong> is a cell-type marker - this is a guanine nucleotide exchange factor
                critically involved in immune cell migration and dendritic cell function. Its expression as a defining
                marker suggests these cells have some baseline immune-interface capacity.</li>
              <li>However, being more distant from fenestrated capillaries, the effect would be weaker.</li>
            </ul>
            <p><strong>4. β1-tanycytes and CVO-associated tanycytes - least effect at ME specifically</strong></p>
            <ul>
              <li>β1 (5245) maps to dorsal PVi, far from ME vasculature.</li>
              <li>NN_1 clusters (5243, 5244) are at other CVOs (SFO, OVLT, choroid plexus) - they would show immune
                activation from vascular exposure at <em>their respective locations</em>, but not from ME-specific
                vascularization.</li>
            </ul>
            <h3>Mechanistic rationale</h3>
            <p>The key biological principle is <strong>gradient of vascular exposure</strong>: the ME has fenestrated
              capillaries without BBB ÔåÆ ╬▓2-tanycytes (floor of 3rd ventricle, processes in ME parenchyma) are
              maximally exposed ÔåÆ ╬▓1-tanycytes (lateral ME/ventral ARH) have partial exposure ÔåÆ β-tanycytes (more
              dorsal) are progressively shielded. During aging, peripheral inflammatory load increases
              (&quot;inflammaging&quot;), and the cells with the most direct vascular contact will show the strongest
              transcriptional upregulation of innate immune programs (MHC-I, interferon-stimulated genes, complement,
              NF-╬║B targets).</p>
            <h3>Remaining uncertainty</h3>
            <ul>
              <li>The graph database captures steady-state adult markers, not aging dynamics - the prediction is based
                on anatomical position and vascular exposure logic rather than direct aging transcriptomic data.</li>
              <li>Whether immune program upregulation is cell-autonomous (direct cytokine sensing) or paracrine (via
                ME-resident microglia/macrophages signaling to tanycytes) cannot be distinguished from this data alone.
              </li>
            </ul>
          </div>
          <span class="show-toggle">show more</span>
        </div>
      </div>
      <div class="cell plain">
        <div class="cell-section-label">Reasoning</div>
        <div class="cell-content">
          <div class="reasoning-body collapsed"> Here&#39;s the reasoning:
            <h3>Anatomical logic</h3>
            <p>Tanycytes are arrayed along a dorsoventral gradient on the walls and floor of the third ventricle, and
              their subtypes differ critically in what they contact:</p>
            <table>
              <thead>
                <tr>
                  <th>Subtype</th>
                  <th>Position</th>
                  <th>Vascular contact</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td>α1</td>
                  <td>Dorsal (VMH region)</td>
                  <td>Standard BBB vasculature</td>
                </tr>
                <tr>
                  <td>α2</td>
                  <td>Intermediate (arcuate)</td>
                  <td>Standard BBB vasculature</td>
                </tr>
                <tr>
                  <td><strong>β1</strong></td>
                  <td>Lateral ME</td>
                  <td>Approaching fenestrated capillaries</td>
                </tr>
                <tr>
                  <td><strong>β2</strong></td>
                  <td>Floor / ventral ME</td>
                  <td><strong>Processes terminate directly on fenestrated portal capillaries</strong></td>
                </tr>
              </tbody>
            </table>
            <p>The median eminence is a <strong>circumventricular organ</strong> — its capillary plexus is fenestrated
              and lacks a conventional blood-brain barrier. This means blood-borne cytokines, DAMPs, and other
              inflammatory mediators have direct access.</p>
            <h3>Why β2 tanycytes specifically</h3>
            <p><strong>β2 tanycytes</strong> are the subtype whose end-feet directly abut the fenestrated perivascular
              space of the ME. During aging, systemic &quot;inflammaging&quot; elevates circulating pro-inflammatory
              factors (TNFα, IL-6, IL-1β, etc.). Because β2 tanycytes are the first CNS-resident cells to encounter
              these signals without BBB filtering, they would be expected to show the <strong>strongest transcriptional
                activation of innate immune and interferon-response programs</strong> — including upregulation of genes
              in the MHC-I/II pathway, complement cascade, and NF-κB signaling.</p>
            <p><strong>β1 tanycytes</strong> occupy the lateral ME and have partial exposure to this milieu, so they
              represent a graded, somewhat weaker response.</p>
            <p><strong>α1/α2 tanycytes</strong>, by contrast, sit behind a conventional BBB and are largely shielded
              from peripheral inflammatory signals, so their immune program activation during aging would be
              comparatively modest.</p>
            <h3>Summary</h3>
            <blockquote>
              <p>Given the fenestrated vasculature of the median eminence, <strong>β2 tanycytes</strong> — and to a
                lesser extent <strong>β1 tanycytes</strong> — are the subtypes most directly exposed to age-related
                increases in circulating inflammatory mediators. They would therefore be predicted to show the strongest
                upregulation of immune and inflammatory transcriptional programs with aging.</p>
            </blockquote>
          </div>
          <span class="show-toggle">show more</span>
        </div>
      </div>

      <div class="divider-row"></div>

      <div class="cell kg">
        <div class="cell-section-label">Response</div>
        <div class="cell-content"><b>β2-tanycytes</b> (Tanycyte NN_3) and <b>β1-tanycytes</b> would show the strongest
          increase in immune programs during aging.</div>
      </div>
      <div class="cell plain">
        <div class="cell-section-label">Response</div>
        <div class="cell-content">
          <p>The answer centers on <strong>β2 tanycytes</strong>, with <strong>β1 tanycytes</strong> as a secondary
            candidate.</p>
        </div>
      </div>

      <div class="notes-row">
        <div class="notes-label">Observations</div>
        <div class="notes-content">Bla bla bla</div>
      </div>
    </div>
  </div>

  <!-- QUESTION 2 -->
  <div class="question-block">
    <div class="question-label">Question 2</div>
    <div class="question-text">I want to target genetically somatostatin interneurons of cortex somatosensory layer 4,
      specifically, without targeting any other population among the Sst positive populations. Which gene should I
      target?
    </div>
    <div class="comparison-grid">
      <div class="col-header kg">Opus KG-mcp</div>
      <div class="col-header plain">Opus Plain</div>

      <div class="cell kg">
        <div class="cell-section-label">Reasoning</div>
        <div class="cell-content">
          <div class="reasoning-body collapsed">
            <p><strong>Step 1 - Identify the target population:</strong>
              Among all 96 Sst clusters in the database, I identified which ones are spatially enriched in somatosensory
              cortex layer 4 (SSs4). The top hit is <strong>cluster 799 (Sst Gaba_9)</strong> with 14% of its cells
              mapped to SSs4 - the highest of any Sst cluster by a wide margin (next: cluster 800 at 7%, cluster 801
              at 5%).</p>
            <p><strong>Step 2 - Find unique markers:</strong>
              Cluster 799 has three cell-type markers: <strong>Dysf</strong>, Pdyn, and Prdm1. I tested each for
              uniqueness across all Sst populations:</p>
            <table>
              <thead>
                <tr>
                  <th>Marker</th>
                  <th># other Sst clusters sharing it</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td><strong>Dysf</strong></td>
                  <td><strong>0</strong></td>
                </tr>
                <tr>
                  <td>Pdyn</td>
                  <td>25</td>
                </tr>
                <tr>
                  <td>Prdm1</td>
                  <td>15</td>
                </tr>
              </tbody>
            </table>
            <p><strong>Dysf is a ct_marker for exactly ONE cluster in the entire database</strong> - cluster 799. No
              other Sst cluster, and in fact no other cluster of any type, carries Dysf as a marker.</p>
            <p><strong>Step 3 - Proposed targeting strategy:</strong>
              An intersectional genetic approach using <strong>Sst-Cre ├ù Dysf-Flp</strong> (or equivalent
              dual-recombinase system) would:</p>
            <ul>
              <li>Restrict labeling to Sst+ cells (eliminating all non-interneuron expression)</li>
              <li>Within Sst+, restrict to only cluster 799 (the most L4-somatosensory-enriched Sst type)</li>
              <li>Exclude all other 95 Sst populations</li>
            </ul>
            <h3>Caveats</h3>
            <ul>
              <li>Cluster 799 is enriched in SS L4 (14%) but not exclusive to it - it also appears in VISp layer 4
                (6%) and MOp layer 5 (4%). A viral injection restricted to somatosensory cortex would solve this spatial
                specificity.</li>
              <li>If you need broader coverage of <em>all</em> Sst cells in SS L4 (not just the most enriched cluster),
                consider <strong>Prdm1</strong>, which marks the entire Sst Gaba_9 supertype (clusters 798-801,
                collectively ~27% in SSs4), but at the cost of also marking 15 other Sst clusters elsewhere.</li>
              <li><strong>Zfp618</strong> is also a transcription factor unique to cluster 799 among Sst populations and
                could serve as an alternative.</li>
            </ul>
            <p><strong>Bottom line:</strong> For maximum specificity to Sst+ layer 4 somatosensory interneurons without
              off-targeting other Sst populations, target <strong>Dysf</strong>.</p>
            <b>My follow up:</b> <em>Somebody suggests: "Hpse, since Hpse is the only marker that is specific to that
              population and not others”. Is he right or wrong?</em>
            <br>Opus: <br>
            I already checked Hpse earlier. Let me pull up the data explicitly to evaluate the claim.
            <p><strong>He&#39;s wrong.</strong> Hpse is not specific to the SS L4 Sst population. It is a ct_marker
              shared by <strong>7 different Sst clusters</strong> across 5 different supertypes:</p>
            <table>
              <thead>
                <tr>
                  <th>Cluster</th>
                  <th>Supertype</th>
                  <th>In SSs4?</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td>768</td>
                  <td>Sst Gaba_3</td>
                  <td>No</td>
                </tr>
                <tr>
                  <td>792</td>
                  <td>Sst Gaba_7</td>
                  <td>5%</td>
                </tr>
                <tr>
                  <td>793</td>
                  <td>Sst Gaba_7</td>
                  <td>4%</td>
                </tr>
                <tr>
                  <td>794</td>
                  <td>Sst Gaba_7</td>
                  <td>No</td>
                </tr>
                <tr>
                  <td><strong>800</strong></td>
                  <td><strong>Sst Gaba_9</strong></td>
                  <td><strong>7%</strong></td>
                </tr>
                <tr>
                  <td>816</td>
                  <td>Sst Gaba_15</td>
                  <td>No</td>
                </tr>
                <tr>
                  <td>828</td>
                  <td>Sst Gaba_19</td>
                  <td>No</td>
                </tr>
              </tbody>
            </table>
            <p>Targeting Hpse within an Sst-Cre strategy would hit at least 7 clusters spanning 5 supertypes - most of
              which have nothing to do with somatosensory layer 4. This directly violates the requirement of &quot;not
              targeting any other Sst population.&quot;</p>
            <p><strong>Dysf</strong> remains the correct answer: it marks exactly 1 cluster (799) out of 96 Sst
              clusters, and that cluster is the most SSs4-enriched Sst type in the database.</p>
          </div>
          <span class="show-toggle">show more</span>
        </div>
      </div>
      <div class="cell plain">
        <div class="cell-section-label">Reasoning</div>
        <div class="cell-content">
          <div class="reasoning-body collapsed">
            <p>In the Allen Institute&#39;s transcriptomic taxonomy of adult mouse cortex (Tasic et al., 2018), Sst
              interneurons are split into numerous transcriptomic subtypes. Among these, the <strong>Sst Hpse</strong>
              cluster(s) (e.g., <em>Sst Hpse Cbln4</em>, <em>Sst Hpse Sema3c</em>) are specifically enriched in
              <strong>layer 4 of primary sensory cortices</strong>, including somatosensory barrel cortex (SSp).
            </p>
            <p>Why Hpse works as a discriminating marker:</p>
            <ol>
              <li>
                <p><strong>Layer specificity</strong> - Hpse expression within Sst+ neurons is heavily biased toward
                  L4, where these interneurons provide feedforward inhibition onto excitatory stellate/pyramidal cells
                  receiving thalamocortical input.</p>
              </li>
              <li>
                <p><strong>Exclusion of other Sst populations</strong> - Other major Sst subtypes (e.g., Sst Chodl
                  long-range projecting neurons, Sst Calb2 Martinotti-like cells in L2/3-L5, Sst Chrna2, Sst Myh8,
                  etc.) do <strong>not</strong> co-express Hpse at significant levels, making it a clean discriminator
                  within the Sst lineage.</p>
              </li>
              <li>
                <p><strong>Region enrichment</strong> - Hpse-expressing Sst neurons are enriched in granular sensory
                  cortices (which have a prominent L4), further narrowing expression to somatosensory, visual, and
                  auditory cortex - regions with prominent thalamocortical L4 input.</p>
              </li>
            </ol>
            <h2>Practical Targeting Strategy</h2>
            <p>Use an <strong>intersectional genetic approach</strong>:</p>
            <table>
              <thead>
                <tr>
                  <th>Component</th>
                  <th>Purpose</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td><strong>Sst-Cre</strong> driver line</td>
                  <td>Restricts to all Sst+ interneurons</td>
                </tr>
                <tr>
                  <td><strong>Hpse-FlpO</strong> driver (or Hpse enhancer-driven AAV)</td>
                  <td>Restricts to Hpse+ cells</td>
                </tr>
                <tr>
                  <td><strong>Cre- and Flp-dependent effector</strong> (e.g., dual-recombinase AAV)</td>
                  <td>Only activates at the intersection</td>
                </tr>
              </tbody>
            </table>
            <p>Injecting into somatosensory cortex adds a third layer of spatial restriction, giving you highly specific
              access to L4 Sst interneurons of SSp.</p>
            <h2>Caveats</h2>
            <ul>
              <li>If absolute exclusivity is required, confirm with single-cell RNA-seq data (e.g., Allen Brain Cell
                Atlas) that Hpse is not expressed in any off-target Sst subtype in your specific region of interest.
              </li>
              <li>A small number of Hpse+ Sst neurons may exist in L4 of other sensory cortices (V1, A1), so stereotaxic
                injection coordinates provide the final spatial restriction to somatosensory cortex specifically.</li>
            </ul>
          </div>
          <span class="show-toggle">show more</span>
        </div>
      </div>

      <div class="divider-row"></div>

      <div class="cell kg">
        <div class="cell-section-label">Response</div>
        <div class="cell-content">Answer: <b>Dysf</b> (Dysferlin)</div>
      </div>
      <div class="cell plain">
        <div class="cell-section-label">Response</div>
        <div class="cell-content"><b>Hpse</b> (heparanase) is the gene you should target in an intersectional strategy
          with Sst.</div>
      </div>

      <div class="notes-row">
        <div class="notes-label">Observations</div>
        <div class="notes-content">Different response ! Note that Opus-KG even if prompted with a
          follow-up regarding Hpse, still held its ground. Also plain Opus said to check whether Hpse is expressed in
          any off-target Sst subtype in your specific region, which was exactly what Opus-KG did and why it discarded
          Hpse. -- (from both reasoning lines)</div>
      </div>
    </div>
  </div>

  <!-- QUESTION 3 -->
  <div class="question-block">
    <div class="question-label">Question 3</div>
    <div class="question-text">How many electrophysiologically distinct populations (by populations I mean, typically
      exhibiting different neuropeptides) would light up if I used an enhancer targeting Lamp5?
    </div>
    <div class="comparison-grid">
      <div class="col-header kg">Opus KG-mcp</div>
      <div class="col-header plain">Opus Plain</div>

      <div class="cell kg">
        <div class="cell-section-label">Reasoning</div>
        <div class="cell-content">
          <div class="reasoning-body collapsed">These 26 clusters exhibit <strong>13 unique
              neuropeptide signatures</strong>, which define the electrophysiologically distinct populations:</p>
            <table>
              <thead>
                <tr>
                  <th>#</th>
                  <th>Neuropeptide signature</th>
                  <th>Clusters</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td>1</td>
                  <td>Cort + Npy + Cck + Pnoc</td>
                  <td>706, 709, 710, 724, 725, 726, 731</td>
                </tr>
                <tr>
                  <td>2</td>
                  <td>Cck + Pnoc</td>
                  <td>711, 712, 720, 722, 723</td>
                </tr>
                <tr>
                  <td>3</td>
                  <td>Npy + Cck + Pnoc</td>
                  <td>715, 721, 730</td>
                </tr>
                <tr>
                  <td>4</td>
                  <td>Npy + Pnoc</td>
                  <td>707, 718</td>
                </tr>
                <tr>
                  <td>5</td>
                  <td>Cort + Npy + Pnoc</td>
                  <td>708</td>
                </tr>
                <tr>
                  <td>6</td>
                  <td>Cort + Cck + Pnoc</td>
                  <td>729</td>
                </tr>
                <tr>
                  <td>7</td>
                  <td>Pnoc only</td>
                  <td>713</td>
                </tr>
                <tr>
                  <td>8</td>
                  <td>Npy + Penk + Pnoc + Crh + Tac2</td>
                  <td>714</td>
                </tr>
                <tr>
                  <td>9</td>
                  <td>Crh + Npy + Pnoc</td>
                  <td>717</td>
                </tr>
                <tr>
                  <td>10</td>
                  <td>Npy + Tac2</td>
                  <td>716</td>
                </tr>
                <tr>
                  <td>11</td>
                  <td>Npy + Tac2 + Cck</td>
                  <td>719</td>
                </tr>
                <tr>
                  <td>12</td>
                  <td>Sst + Pnoc + Cort + Tac1</td>
                  <td>727</td>
                </tr>
                <tr>
                  <td>13</td>
                  <td>Pnoc + Cartpt + Cort + Tac1 + Cck</td>
                  <td>728</td>
                </tr>
              </tbody>
            </table>
            <p>Key biological patterns:</p>
            <ul>
              <li><strong>Pnoc (prepronociceptin)</strong> is nearly universal (24/26 clusters), serving as a Lamp5
                lineage signature.</li>
              <li><strong>Cck</strong> and <strong>Npy</strong> are the next most common, splitting the population into
                major subgroups.</li>
              <li><strong>Cort</strong> marks a distinct subset (11 clusters), predominantly in the Lamp5 Lhx6-derived
                (MGE-origin) populations.</li>
              <li>Rare neuropeptides (<strong>Tac1, Tac2, Crh, Penk, Cartpt, Sst</strong>) define the most specialized
                populations, mostly singleton clusters.</li>
              <li>The Lamp5 Lhx6 subclass (MGE-derived) shows richer neuropeptide diversity (Sst, Tac1, Cartpt) compared
                to the CGE-derived Lamp5 Gaba subclass, consistent with their distinct developmental origins.</li>
            </ul>
            <h2>Doubts</h2>
            <ul>
              <li>All neuropeptide markers have <code>avg_log2 = 1.0</code>, so I cannot distinguish dominant vs.
                low-level co-expression. In practice, some neuropeptides may be expressed at sub-functional levels,
                which would reduce the number of truly <em>functionally</em> distinct populations.</li>
              <li>An enhancer&#39;s actual labeling efficiency may not capture all 26 clusters equally - some may
                express Lamp5 at levels below the enhancer&#39;s activation threshold, potentially labeling fewer
                populations in practice.</li>
              <li>The electrophysiological distinctness implied by neuropeptide differences is an approximation; cells
                with identical neuropeptide signatures but different ion channel profiles could still differ
                electrophysiologically.</li>
            </ul>
            <b>My follow up:</b> <em> Ok, just to be clear, what are this 2 subclasses you found and talked about?</em>
            <p>The two Lamp5 subclasses are:</p>
            <ol>
              <li><strong>Lamp5 Gaba</strong> - CGE-derived (caudal ganglionic eminence), 18 clusters</li>
              <li><strong>Lamp5 Lhx6 Gaba</strong> - MGE-derived (medial ganglionic eminence), 8 clusters</li>
            </ol>
            <p>The key distinction is <strong>Lhx6</strong>: it&#39;s a transcription factor that marks MGE-derived
              interneurons. So while both subclasses express Lamp5, they originate from different embryonic progenitor
              zones, giving the Lhx6+ group a distinct molecular and electrophysiological identity (e.g., the unique
              Sst, Tac1, Cartpt neuropeptide markers).</p>
          </div>
          <span class="show-toggle">show more</span>
        </div>
      </div>
      <div class="cell plain">
        <div class="cell-section-label">Reasoning</div>
        <div class="cell-content">
          <div class="reasoning-body collapsed">
            <p>... distinguishable by their neuropeptide profiles: <br><br></p>
            <table>
              <thead>
                <tr>
                  <th>#</th>
                  <th>Neuropeptide Marker</th>
                  <th>Cell Type</th>
                  <th>Electrophysiological Signature</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td>1</td>
                  <td><strong>NPY</strong></td>
                  <td>Neurogliaform cells (Lamp5/Ndnf)</td>
                  <td>Late-spiking, dense local inhibition</td>
                </tr>
                <tr>
                  <td>2</td>
                  <td><strong>SST</strong></td>
                  <td>Lamp5/Lhx6 (MGE-derived)</td>
                  <td>Chandelier-like, fast-spiking features</td>
                </tr>
                <tr>
                  <td>3</td>
                  <td><strong>VIP</strong></td>
                  <td>Lamp5/Pax6 (single-bouquet-like)</td>
                  <td>Irregular/adapting spiking</td>
                </tr>
                <tr>
                  <td>4</td>
                  <td><strong>NOS1 (nNOS)</strong></td>
                  <td>Long-range projecting Lamp5 cells</td>
                  <td>Burst-spiking, long-range GABAergic projection</td>
                </tr>
              </tbody>
            </table>
            <h3>Key reasoning:</h3>
            <ul>
              <li><strong>Lamp5</strong> marks a subclass of CGE-derived (and some MGE-derived) GABAergic interneurons
              </li>
              <li>The <strong>Lamp5/Lhx6</strong> population is notable because it is MGE-derived (unlike most Lamp5
                cells) and co-expresses <strong>SST</strong> - electrophysiologically it resembles chandelier cells
              </li>
              <li>The <strong>neurogliaform</strong> (Lamp5/Ndnf/<strong>NPY+</strong>) population is the canonical
                Lamp5 type with a distinctive late-spiking phenotype and volume transmission of GABA</li>
              <li><strong>nNOS+</strong> Lamp5 cells are a distinct long-range projecting population with burst-spiking
                properties</li>
              <li>Some subtypes co-express <strong>VIP</strong> or <strong>CCK</strong>, but VIP marks the more
                electrophysiologically distinct group among these</li>
            </ul>
            <p>So the short answer: <strong>4</strong> electrophysiologically distinct neuropeptide-defined populations
              would light up with a Lamp5 enhancer.</p>
          </div>
          <span class="show-toggle">show more</span>
        </div>
      </div>

      <div class="divider-row"></div>

      <div class="cell kg">
        <div class="cell-section-label">Response</div>
        <div class="cell-content">
          <p><strong>13 distinct neuropeptide-defined populations</strong> would light up with a Lamp5 enhancer. A Lamp5
            enhancer would label <strong>26 clusters</strong> spanning <strong>2 subclasses</strong> (Lamp5
            Gaba, Lamp5 Lhx6 Gaba) and <strong>5 supertypes</strong>.
        </div>
      </div>
      <div class="cell plain">
        <div class="cell-section-label">Response</div>
        <div class="cell-content">Based on the transcriptomic taxonomy of the adult mouse brain (Allen Brain Cell Atlas;
          Tasic et al. 2018; Gouwens et al. 2020; Yao et al. 2021, 2023), an enhancer targeting <b>Lamp5</b> would label
          <b>~4 major electrophysiologically distinct populations</b>, distinguishable by their neuropeptide profiles:
        </div>
      </div>

      <div class="notes-row">
        <div class="notes-label">Observations</div>
        <div class="notes-content">Bla bla</div>
      </div>
    </div>
  </div>

  <!-- QUESTION 4 -->
  <div class="question-block">
    <div class="question-label">Question 4</div>
    <div class="question-text">Consider the two parvalbuminergic subtypes Pvalb basket and Pvalb chandelier in the
      primary somatosensory area S1 brain region. Do we expect one of the two cell types to be more frequently positive
      to Pvalb or are they expected to have similar Pvalb positivity proportions?
    </div>
    <div class="comparison-grid">
      <div class="col-header kg">Opus KG-mcp</div>
      <div class="col-header plain">Opus Plain</div>

      <div class="cell kg">
        <div class="cell-section-label">Reasoning</div>
        <div class="cell-content">
          <div class="reasoning-body collapsed">
            <h3>Evidence from the graph</h3>
            <ul>
              <li>In the Allen Brain Cell Atlas taxonomy encoded here, there are 2 chandelier clusters (732, 733) under
                subclass <code>Pvalb chandelier Gaba</code> and 22 basket-type clusters (734-755) under subclass
                <code>Pvalb Gaba</code>.
              </li>
              <li><strong>Pvalb is listed as a cluster-level differentiating marker (<code>Has_ct_marker</code>) for 1
                  basket cluster (cluster:740) but for zero chandelier clusters.</strong> This signals that Pvalb
                expression is high enough in some basket clusters to serve as a distinguishing marker at fine
                resolution, but never reaches that status in chandelier cells.</li>
              <li>The chandelier clusters instead carry distinct markers like <strong>Pthlh</strong>,
                <strong>Krt12</strong>, and <strong>Sfta3-ps</strong> - known chandelier-specific genes - while
                Pvalb itself is not among them.
              </li>
            </ul>
            <h3>Biological reasoning</h3>
            <ol>
              <li>
                <p><strong>Expression levels</strong>: Single-cell RNA-seq studies (including the Allen ABC Atlas
                  underlying this graph) consistently show that Pvalb basket cells express <em>Pvalb</em> at
                  <strong>higher average levels</strong> than chandelier cells. Chandelier cells have more variable,
                  lower-magnitude Pvalb transcription.
                </p>
              </li>
              <li>
                <p><strong>Immunohistochemical detection</strong>: Because chandelier cells express Pvalb at lower
                  levels, a substantial fraction fall <strong>below detection thresholds</strong> in standard anti-Pvalb
                  immunostaining. Studies in mouse somatosensory cortex have shown that many morphologically confirmed
                  chandelier cells are Pvalb-immunonegative, while basket cells are more uniformly Pvalb-positive.</p>
              </li>
              <li>
                <p><strong>Developmental and functional context</strong>: Chandelier cells (axo-axonic cells) and basket
                  cells arise from the medial ganglionic eminence but diverge in maturation. Basket cells upregulate
                  Pvalb earlier and maintain higher steady-state levels, consistent with their higher firing rates and
                  greater metabolic demand for calcium buffering. Chandelier cells, while still Pvalb-lineage, rely on
                  additional markers (Pthlh, Vipr2) for their identity and have a more heterogeneous Pvalb expression
                  profile.</p>
              </li>
            </ol>
            <h3>Conclusion</h3>
            <p>In S1 (primary somatosensory cortex), <strong>Pvalb basket cells should show a higher proportion of
                Pvalb-positive cells</strong> compared to chandelier cells. Both types belong to the Pvalb family, but
              chandelier cells express the gene at lower and more variable levels, leading to a lower &quot;positivity
              rate&quot; - particularly when assessed by protein-level methods like immunohistochemistry.</p>

          </div>
          <span class="show-toggle">show more</span>
        </div>
      </div>
      <div class="cell plain">
        <div class="cell-section-label">Reasoning</div>
        <div class="cell-content">
          <div class="reasoning-body collapsed">
            <p>Although both subtypes are classified under the Pvalb transcriptomic class, they differ meaningfully in
              their parvalbumin expression levels:</p>
            <p><strong>Pvalb basket cells:</strong></p>
            <ul>
              <li>Express Pvalb at consistently high levels - it is one of their most robust and defining markers.
              </li>
              <li>Virtually all basket cells are detectably Pvalb-positive regardless of assay (scRNA-seq, FISH, IHC).
              </li>
            </ul>
            <p><strong>Pvalb chandelier cells:</strong></p>
            <ul>
              <li>Express Pvalb at <strong>lower and more variable</strong> levels compared to basket cells.</li>
              <li>Single-cell transcriptomic studies (including Allen Brain Cell Atlas data) consistently show that
                chandelier cells sit at the lower end of the Pvalb expression distribution within the broader Pvalb
                class.</li>
              <li>A non-trivial fraction of chandelier cells can fall below detection thresholds, particularly in less
                sensitive assays, reducing their apparent Pvalb-positivity rate.</li>
            </ul>
            <h3>Why the difference?</h3>
            <ol>
              <li>
                <p><strong>Distinct transcriptomic identity.</strong> Chandelier cells occupy a separate transcriptomic
                  branch from basket cells. While both derive from the medial ganglionic eminence and share core
                  PV-interneuron features, chandelier cells have a divergent gene-regulatory program that results in
                  lower baseline Pvalb transcription.</p>
              </li>
              <li>
                <p><strong>Functional correlate.</strong> Basket cells are the canonical fast-spiking perisomatic
                  inhibitors with very high metabolic demands, and Pvalb (a calcium buffer) is tightly coupled to that
                  physiology. Chandelier cells, which target the axon initial segment, have a partially different
                  electrophysiological and metabolic profile, consistent with somewhat lower calcium-buffering
                  requirements.</p>
              </li>
              <li>
                <p><strong>Empirical evidence.</strong> Patch-seq and MERFISH datasets from mouse cortex (including S1)
                  show that Pvalb transcript counts are systematically lower in chandelier-mapped clusters compared to
                  basket-mapped clusters.</p>
              </li>
            </ol>
            <h3>Summary</h3>
            <table>
              <thead>
                <tr>
                  <th>Feature</th>
                  <th>Pvalb Basket</th>
                  <th>Pvalb Chandelier</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td>Pvalb expression level</td>
                  <td>High, consistent</td>
                  <td>Lower, variable</td>
                </tr>
                <tr>
                  <td>Expected Pvalb positivity</td>
                  <td>~Near 100%</td>
                  <td>Appreciably lower</td>
                </tr>
                <tr>
                  <td>Relative abundance in S1</td>
                  <td>More common</td>
                  <td>Rare</td>
                </tr>
              </tbody>
            </table>
            <p><strong>Bottom line:</strong> We expect Pvalb basket cells to show a meaningfully higher Pvalb-positivity
              proportion than chandelier cells in S1, driven by intrinsic differences in transcriptional regulation of
              the <em>Pvalb</em> gene between these two subtypes.</p>

          </div>
          <span class="show-toggle">show more</span>
        </div>
      </div>

      <div class="divider-row"></div>

      <div class="cell kg">
        <div class="cell-section-label">Response</div>
        <div class="cell-content">Pvalb basket cells are expected to have higher Pvalb positivity proportions than Pvalb
          chandelier cells.
        </div>
      </div>
      <div class="cell plain">
        <div class="cell-section-label">Response</div>
        <div class="cell-content">Pvalb basket cells are expected to have a higher Pvalb-positivity proportion than
          Pvalb chandelier cells.
        </div>
      </div>

      <div class="notes-row">
        <div class="notes-label">Observations</div>
        <div class="notes-content">Bla bla</div>
      </div>
    </div>
  </div>

  <script>
    document.querySelectorAll('.show-toggle').forEach(toggle => {
      const body = toggle.previousElementSibling;
      toggle.addEventListener('click', () => {
        const isCollapsed = body.classList.contains('collapsed');
        body.classList.toggle('collapsed', !isCollapsed);
        toggle.textContent = isCollapsed ? 'show less' : 'show more';
      });
    });
  </script>

</body>

</html>
